Consensus Pharma Mar, S.A.

Equities

PHM

ES0169501022

Market Closed - BME Other stock markets 11:35:10 2024-05-03 am EDT			5-day change	1st Jan Change
31.14 ^EUR	+0.71%		+7.53%	-24.20%

Apr. 23	Pharma Mar, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Feb. 29	Transcript : Pharma Mar, S.A., 2023 Earnings Call, Feb 29, 2024

Evolution of the average Target Price on Pharma Mar, S.A.

Price target over the last 5 years

History of analyst recommendation changes

3ee145756ea43f2e4b24ab4a61c.eoeiZtK1yqQ20VcFY2JS0ANIlzRAM0qqvYyZ0cFfBt8.LbHbBZ7jq51AgmBfWxQrs2kap3AnZi2b7-_uhK5yd5c8zdYN5-W5x0-TNA~2fbf4967677bf44c8e2933964c8e2a76

Analyst Recommendations on Pharma Mar, S.A.

PharmaMar - The PROFARMA program grants PharmaMar an 'Excellent' company rating	22-10-17	AQ
TODAY'S ANALYST RECOMMENDATIONS : Cisco, easyJet, L Brands, Mattel, Salesforce...	21-05-21